Clinical trial
The Treatment of Insomnia in Patients With HIV Disease
NCT00465972 · Duke University, Other · Completed
Key facts
| NCT number | NCT00465972 |
|---|---|
| Title | The Treatment of Insomnia in Patients With HIV Disease |
| Official title | A Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of Doxepin and Temazepam in HIV Seropositive Patients With Insomnia. |
| Lead sponsor | Duke University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections, Insomnia |
| Intervention type | Drug |
| Interventions | Doxepin, Temazepam, Placebo |
| Enrollment | 44 |
| Start date | Mar 1, 2007 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Apr 27, 2007 |
| Last update posted | Jul 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: